Private briefings for boards, leadership teams, investors and decision-makers who need to understand the genomic power shift without getting lost in technical detail.
These briefings translate complex developments in genomics, AI and biotechnology into clear strategic insight. They help senior teams understand what is changing, why it matters, where the opportunities are, and what risks deserve attention.
Briefings can cover
- What genomics is and why it matters now
- How AI is changing biology and drug discovery
- Precision medicine and the future of healthcare
- Genomic data, privacy and regulation
- Biosecurity and synthetic biology
- Consumer genomics, fertility and identity
- Biodiversity, agriculture and food systems
- Investment trends in genomics and biotech
Interested in working together?
For speaking, media, investment, strategy or advisory enquiries, get in touch.